Detalhe da pesquisa
1.
Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer.
Int J Cancer
; 153(1): 224-237, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36799619
2.
Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy.
Cancer Immunol Immunother
; 72(5): 1199-1208, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36369379
3.
Intratumoral PD-1+CD8+ T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer.
Br J Cancer
; 127(9): 1709-1717, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36002752
4.
Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer.
J Immunother Cancer
; 10(2)2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35110359